Drugs · Brain health technique
GM-CSF (Sargramostim / Leukine®)
Evidence grade: Experimental

A recombinant human granulocyte–macrophage colony-stimulating factor (GM-CSF) that stimulates innate immune activity and neuroinflammatory repair mechanisms; marketed as Leukine®, used in oncology and being tested for Alzheimer’s.
- Practice
- Drugs
- Principle
- Treatment
- Tactic
- Neuroprotective & Disease-modifying Therapies
- Evidence grade
- Experimental
- Strength of evidence
- Low
How to practice GM-CSF (Sargramostim / Leukine®)
Currently investigational for neurodegenerative use. Administered as subcutaneous injections (typically 250 µg/m² daily for 5 days/week over 3 weeks in trials). Available clinically only for hematologic and transplant indications. Off-label use not recommended outside clinical research due to uncertain safety and optimal dosing for brain health.
The evidence behind GM-CSF (Sargramostim / Leukine®)
GM-CSF is a natural signal that tells your bone marrow to make more white blood cells. Sargramostim is a lab-made version of it. Doctors use sargramostim to help rebuild white blood cell counts after chemotherapy or a bone marrow transplant, which lowers the risk of serious infection.
Impact on brain health
Early clinical trial data in people with mild to moderate Alzheimer's show that sargramostim improved scores on one cognitive assessment and lowered blood markers of tau and nerve cell damage. Researchers think sargramostim works by reactivating microglia and calling in protective immune responses that clear debris and help neurons repair. That mechanism is unproven in people, and the data are still preliminary, from a small group studied for a short time.
Reviewed by BetterBrain's clinical advisors · Updated November 2026 · Our science
More Drugs techniques
Pair this with other habits from the same practice.

Evidence grade: Context Dependent
Anti-Amyloid Monoclonal Antibodies
FDA-approved biologic drugs that target beta-amyloid plaques to slow Alzheimer’s progression, including lecanemab (Leqembi®), donanemab (Kisunla™).

Evidence grade: Context Dependent
Antihypertensives
Medications that lower blood pressure to protect vascular and brain health, including ACE inhibitors (lisinopril, enalapril), ARBs (losartan, valsartan), calcium channel blockers…

Evidence grade: Context Dependent
GLP-1 Receptor Agonists
A class of injectable or oral medications that mimic the hormone glucagon-like peptide-1 (GLP-1) to improve insulin sensitivity, suppress appetite, and reduce inflammation.
Take control of your brain health
BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.